Zenas BioPharma (ZBIO) Revenue (2023 - 2025)
Zenas BioPharma (ZBIO) recorded quarterly Revenue of $10.0 million in Q1 2025, up 100.0% quarter-over-quarter from $5.0 million in Q4 2024.
Zenas BioPharma (ZBIO) Revenue (2023 - 2025) Analysis & Trends
Zenas BioPharma's Revenue history runs 3 years deep, the most recent figure standing at $10.0 million for Q1 2025.
- In Q1 2025, Revenue changed N/A year-over-year to $10.0 million; the TTM figure through Dec 2025 stood at $10.0 million (up 100.0% YoY), while the FY2025 annual figure was $10.0 million, up 100.0% from the prior year.
- Revenue was $10.0 million for Q1 2025 at Zenas BioPharma, up from $5.0 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $50.0 million in Q3 2023 to a low of $5.0 million in Q4 2024.
- Historically, Revenue has averaged $21.7 million across 3 years, with a median of $10.0 million in 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zenas BioPharma | 1.10 Bn | 379.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2023 | 50.00 Mn |